¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦42Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Ãá°èÇмú´ëȸ 밎 Á¦16Â÷ ±¹Á¦½ÉÆ÷Áö¾ö (KCR2022) 3ÀÏÂ÷ : 2022-05-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦42Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Ãá°èÇмú´ëȸ 밎 Á¦16Â÷ ±¹Á¦½ÉÆ÷Áö¾ö (KCR2022) 3ÀÏÂ÷ : 2022-05-21
±³À°ÀÏÀÚ : 2022-05-21
±³À°Àå¼Ò : µå·¡°ï½ÃƼ (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà)  
±³À°ÁÖÁ¦ : Á¦42Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Ãá°èÇмú´ëȸ 밎 Á¦16Â÷ ±¹Á¦½ÉÆ÷Áö¾ö (KCR2022) 3ÀÏÂ÷
ÁÖÃÖ±â°ü : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
´ã´çÀÚ : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
¿¬¶ôó : 02-794-2630  
À̸ÞÀÏ : webmaster@rheum.or.kr      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ¿µ»óÀÇÇаú, ÀçÈ°ÀÇÇаú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 18 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í È¸¿ø Àü¹®ÀÇ 120,000¿ø, ȸ¿ø Àü°øÀÇ 60,000¿ø ºñȸ¿ø Àü¹®ÀÇ 150,000¿ø, ºñȸ¿ø Àü°øÀÇ 80,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-21 ROOM A 08:00~08:40 Biosimilar: Past, present and future  È«½ÂÀç(°æÈñÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM A 09:00~10:00 The future of rheumatology  Antony Rosen(Johns Hopkins, USA) 
±³À°½Ã°£ 05-21 ROOM A 10:30~11:00 Hype and truth - treatment paradigm of osteoarthritis  David Hunter(Univ. of Sydney, Australia) 
±³À°½Ã°£ 05-21 ROOM A 11:00~11:30 Addicted to preion, medical abuse of osteoarthritis  Yuqing Zhang(Massachusetts General Hosp., USA) 
±³À°½Ã°£ 05-21 ROOM A 11:30~12:00 Use or abuse? APM for degenerative meniscus in osteoarthritis  ±èÇö¾Æ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM A 12:00~12:40 The role of IL-17A in axial spondyloarthritis and axial PsA  Matthew Brown(Kings College London, UK) 
±³À°½Ã°£ 05-21 ROOM A 13:00~13:30 Synovial macrophages as gatekeepers of inflammation  Gerhard Krönke(Alexander Univ. Erlangen, Germany) 
±³À°½Ã°£ 05-21 ROOM A 13:30~14:00 Notch signalling drives synovial fibroblast identity and arthritis pathology  Soumya Raychaudhuri(Brigham and Women¡¯s Hosp. and Harvard Medical School, USA) 
±³À°½Ã°£ 05-21 ROOM A 14:00~14:30 Roles of stromal cells and potential significance for future therapy in RA  ÀÌ»óÀÏ(°æ»óÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM A 15:30~16:00 Update in the pathogenesis of systemic sclerosis  Christopher Denton(Royal Free Hosp., UK) 
±³À°½Ã°£ 05-21 ROOM A 16:00~16:30 Update in interstitial lung disease in SSc  Oliver Distler(Univ. Hosp. Zurich, Switzerland) 
±³À°½Ã°£ 05-21 ROOM A 16:30~17:00 Update in pulmonary arterial hypertension in SSc  ÀÌÀººÀ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 08:00~08:40 IL-17 inhibition in spondyloarthritis: The efficacy of Ixekizumab and clinical relevance  ÀÌ¿¬¾Æ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 10:30~12:00 Free Paper Session – Spondyloarthritis  ±¸¿¬(¹ßÇ¥ ¼¼¼Ç) 
±³À°½Ã°£ 05-21 ROOM B 12:00~12:40 Denosumab key clinical questions  ±è¼º¼ö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 13:00~13:30 Anabolic therapy for osteoporosis  ±èÇÏ¿µ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 13:30~14:00 Ideal sequential therapy in osteoporosis management  ±è°æ¹Î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 14:00~14:30 Prevention and treatment of fracture in RA  ¹ÎÁرâ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 15:30~17:00 Free Paper Session – Rheumatoid Arthritis Basic Research  ±¸¿¬(¹ßÇ¥ ¼¼¼Ç) 
±³À°½Ã°£ 05-21 ROOM C 08:00~08:40 Long-lasting Golimumab in AS: Learnings real-world evidence  ±¸º»»ê(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM C 10:30~12:00 Free Paper Session – Systemic Lupus Erythematosus  ±¸¿¬(¹ßÇ¥ ¼¼¼Ç) 
±³À°½Ã°£ 05-21 ROOM C 12:00~12:40 Tacrolimus in rhematoid arthritis  ÃÖÂù¹ü(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM C 13:00~14:30 Free Paper Session – Vasculitis and Metabolic Bone Disease  ±¸¿¬(¹ßÇ¥ ¼¼¼Ç) 
±³À°½Ã°£ 05-21 ROOM C 15:30~16:00 Rheumatic diseases and KCD 8th revision  ±è¼®ÀÏ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM C 16:00~16:30 Principles and future prospects of insurance benefits in rheumatoid diseases  ¼­±âÇö(°Ç°­º¸Çè½É»çÆò°¡¿ø) 
±³À°½Ã°£ 05-21 ROOM C 16:30~17:00 Insurance guideline and tips for treatment of rheumatic disease  È«½ÂÀç(°æÈñÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦42Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Ãá°èÇмú´ëȸ 밎 Á¦16Â÷ ±¹Á¦½ÉÆ÷Áö¾ö (KCR2022) 3ÀÏÂ÷ : 2022-05-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022 ´ëÀü±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2022-05-21
´ÙÀ½±Û Á¦52ȸ ´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸ day2 : 2022-05-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 4 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 7 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 112 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 17 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 75 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 12 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 8 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 7 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 27 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 3 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 8 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 10 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 7 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 11 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷